Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02769637 · ClinicalTrials.gov registry record
Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
A clinical trial, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- 2
- Enrollment target
NCT02769637 is a clinical trial that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 2 participants.
The verdict
NCT02769637 was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
Mucus in the airways of patients with CF represents an area for bacteria proliferation, microbial infection and inflammation. Similar to the lung, the esophagus provides an environment for bacterial to grow. The overall goal of this proposal is to characterize the esophageal microbiota of children with CF that are treated or untreated with acid blockade medication and to measure its possible impact on respiratory disease to develop novel treatment strategies.
Interventions
- DRUG PPI treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-09-07 |
| Est. Completion | 2018-01-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02769637
The ClinicalTrials.gov registry entry for NCT02769637 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PPI treatment is the first listed.
NCT02769637 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02769637 about?
NCT02769637 is a clinical study titled "Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)". Mucus in the airways of patients with CF represents an area for bacteria proliferation, microbial infection and inflammation. Similar to the lung, the esophagus provides an environment for bacterial to grow. The overall goal of this proposal is to characterize the esophageal microbiota of children w...
What is the current status of trial NCT02769637?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2017-09-07. Estimated completion is 2018-01-18.
What interventions are being tested in trial NCT02769637?
The interventions under investigation include: PPI treatment (DRUG).
Who is sponsoring clinical trial NCT02769637?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.